RARE 净利润历史(2016–2025)
Ultragenyx Pharmaceutical Inc. (RARE) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
-$575.0MFY2025 · FY2016 以来:-$245.9M → -$575.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$575.0M | -1.1% |
| FY2024 | -$569.0M | +6.3% |
| FY2023 | -$607.0M | +14.2% |
| FY2022 | -$707.4M | -55.8% |
| FY2021 | -$454.0M | -143.4% |
| FY2020 | -$186.6M | +53.7% |
| FY2019 | -$402.7M | -103.8% |
| FY2018 | -$197.6M | +34.6% |
| FY2017 | -$302.1M | -22.9% |
| FY2016 | -$245.9M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议